Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Yagi

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
American Journal of Respiratory and Critical Care Medicine|July 17, 2013
Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumoniaYuichiro Shindo, Ryota Ito, Daisuke Kobayashi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 4, 2025
Antimicrobial use in pediatric patients: a subgroup analysis of the 2020 point prevalence survey in Aichi, JapanHiroshi Morioka, Kenta Ito, Yusuke Koizumi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 25, 2024
Surgical antimicrobial prophylaxis in Japanese hospitals: Real status and challengesHiroshi Morioka, Yusuke Koizumi, Toshitaka Watariguchi, et al.
The Journal of Hospital Infection|April 30, 2025
Antimicrobial use in Japanese hospitals: results from point prevalence survey in Aichi, 2020Hiroshi Morioka, Yusuke Koizumi, Keisuke Oka, et al.
Infection Control and Hospital Epidemiology|October 8, 2024
Healthcare-associated infections in Japanese hospitals: results from a large-scale multicenter point-prevalence survey in Aichi, 2020Hiroshi Morioka, Yusuke Koizumi, Keisuke Oka, et al.
Journal of Global Antimicrobial Resistance|April 16, 2022
Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in JapanKeisuke Oka, Akane Matsumoto, Nobuyuki Tetsuka, et al.
Science Translational Medicine|September 17, 2025
Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infectionHyeongki Park, Naotoshi Nakamura, Sho Miyamoto, et al.
The Japanese Journal of Antibiotics|January 9, 2014
[Multicenter surveillance of Pseudomonas aeruginosa strains for antimicrobials in Aichi prefecture in 2009]Mitsutaka Iguchi, Mariko Mochizuki, Tetsuya Yagi, et al.
The Japanese Journal of Antibiotics|June 25, 2014
[Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2012]Keizo Yamaguchi, Yoshikazu Ishii, Kazuhiro Tateda, et al.
American Journal of Infection Control|June 7, 2022
Correlation between antibiotic use and antibiotic resistance: A multicenter study using the Japan Surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) system in Hokkaido, JapanKeisuke Kagami, Nobuhisa Ishiguro, Sumio Iwasaki, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
American Journal of Respiratory and Critical Care Medicine|July 17, 2013
Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumoniaYuichiro Shindo, Ryota Ito, Daisuke Kobayashi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 4, 2025
Antimicrobial use in pediatric patients: a subgroup analysis of the 2020 point prevalence survey in Aichi, JapanHiroshi Morioka, Kenta Ito, Yusuke Koizumi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 25, 2024
Surgical antimicrobial prophylaxis in Japanese hospitals: Real status and challengesHiroshi Morioka, Yusuke Koizumi, Toshitaka Watariguchi, et al.
The Journal of Hospital Infection|April 30, 2025
Antimicrobial use in Japanese hospitals: results from point prevalence survey in Aichi, 2020Hiroshi Morioka, Yusuke Koizumi, Keisuke Oka, et al.
Infection Control and Hospital Epidemiology|October 8, 2024
Healthcare-associated infections in Japanese hospitals: results from a large-scale multicenter point-prevalence survey in Aichi, 2020Hiroshi Morioka, Yusuke Koizumi, Keisuke Oka, et al.
Journal of Global Antimicrobial Resistance|April 16, 2022
Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in JapanKeisuke Oka, Akane Matsumoto, Nobuyuki Tetsuka, et al.
Science Translational Medicine|September 17, 2025
Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infectionHyeongki Park, Naotoshi Nakamura, Sho Miyamoto, et al.
The Japanese Journal of Antibiotics|January 9, 2014
[Multicenter surveillance of Pseudomonas aeruginosa strains for antimicrobials in Aichi prefecture in 2009]Mitsutaka Iguchi, Mariko Mochizuki, Tetsuya Yagi, et al.
The Japanese Journal of Antibiotics|June 25, 2014
[Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2012]Keizo Yamaguchi, Yoshikazu Ishii, Kazuhiro Tateda, et al.
American Journal of Infection Control|June 7, 2022
Correlation between antibiotic use and antibiotic resistance: A multicenter study using the Japan Surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) system in Hokkaido, JapanKeisuke Kagami, Nobuhisa Ishiguro, Sumio Iwasaki, et al.
Pageof 16